NO20013101L - Ytre overflateproteiner, deres gener og deres anvendelse - Google Patents
Ytre overflateproteiner, deres gener og deres anvendelseInfo
- Publication number
- NO20013101L NO20013101L NO20013101A NO20013101A NO20013101L NO 20013101 L NO20013101 L NO 20013101L NO 20013101 A NO20013101 A NO 20013101A NO 20013101 A NO20013101 A NO 20013101A NO 20013101 L NO20013101 L NO 20013101L
- Authority
- NO
- Norway
- Prior art keywords
- genes
- surface proteins
- streptococcus
- immunization
- vaccines
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000018697 Membrane Proteins Human genes 0.000 title 1
- 108010052285 Membrane Proteins Proteins 0.000 title 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1018—Carboxy- and carbamoyl transferases (2.1.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
- C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828346.8A GB9828346D0 (en) | 1998-12-22 | 1998-12-22 | Protein and compositions containing it |
| GBGB9901234.6A GB9901234D0 (en) | 1999-01-20 | 1999-01-20 | Protein and compositions containing it |
| GBGB9901233.8A GB9901233D0 (en) | 1999-01-20 | 1999-01-20 | Protein and compositions containing it |
| GBGB9908321.4A GB9908321D0 (en) | 1999-04-12 | 1999-04-12 | Purine nucleoside phosphatase and compositions containing it |
| GBGB9912036.2A GB9912036D0 (en) | 1999-05-24 | 1999-05-24 | Glucose-6-phosphate isomerase and compositions containing it |
| GBGB9922596.3A GB9922596D0 (en) | 1999-09-23 | 1999-09-23 | Protein and compositions containing it |
| PCT/GB1999/004376 WO2000037490A2 (fr) | 1998-12-22 | 1999-12-22 | Proteines de surface exterieure, leurs genes, et leur utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013101D0 NO20013101D0 (no) | 2001-06-21 |
| NO20013101L true NO20013101L (no) | 2001-08-13 |
Family
ID=27547330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013101A NO20013101L (no) | 1998-12-22 | 2001-06-21 | Ytre overflateproteiner, deres gener og deres anvendelse |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US7217415B1 (fr) |
| EP (2) | EP1140994B1 (fr) |
| JP (1) | JP2002533065A (fr) |
| KR (4) | KR100818815B1 (fr) |
| CN (3) | CN1733800A (fr) |
| AP (1) | AP2006003504A0 (fr) |
| AT (1) | ATE297995T1 (fr) |
| AU (1) | AU758722B2 (fr) |
| BR (1) | BR9916473A (fr) |
| CA (1) | CA2354843A1 (fr) |
| CZ (1) | CZ20012174A3 (fr) |
| DE (1) | DE69925866T2 (fr) |
| DK (1) | DK1140994T3 (fr) |
| EA (1) | EA009885B1 (fr) |
| ES (1) | ES2241352T3 (fr) |
| HK (1) | HK1039339A1 (fr) |
| HU (1) | HUP0201022A3 (fr) |
| NO (1) | NO20013101L (fr) |
| NZ (4) | NZ542777A (fr) |
| OA (1) | OA12425A (fr) |
| PL (1) | PL351027A1 (fr) |
| PT (1) | PT1140994E (fr) |
| SI (1) | SI1140994T1 (fr) |
| WO (1) | WO2000037490A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000037646A2 (fr) * | 1998-12-22 | 2000-06-29 | Microscience Limited | Genes, proteines, et leur utilisation |
| CA2354843A1 (fr) * | 1998-12-22 | 2000-06-29 | Microscience Limited | Proteines de surface exterieure, leurs genes, et leur utilisation |
| US6890539B2 (en) * | 1998-12-22 | 2005-05-10 | Microscience, Ltd. | Genes and proteins, and their use |
| WO2008152448A2 (fr) * | 2006-12-21 | 2008-12-18 | Emergent Product Development Uk Limited | Protéines et leur utilisation |
| CN103060284A (zh) * | 2012-10-31 | 2013-04-24 | 内蒙古民族大学 | 一种无乳链球菌pgk亚单位重组蛋白及其制备方法 |
| CN110669711A (zh) * | 2019-08-09 | 2020-01-10 | 中国水产科学研究院珠江水产研究所 | 基于pgk基因的重组乳酸乳球菌和无乳链球菌病疫苗 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3678702D1 (de) * | 1985-12-28 | 1991-05-16 | Ohgen Research Lab Ltd | Antitumorprotein-gen von streptococcus pyogenes su, plasmide, die das gen enthalten, transformantenzellen, die die plasmide beherbergen, und verfahren zur herstellung des antitumorproteins. |
| US5328996A (en) * | 1989-03-29 | 1994-07-12 | University Of Florida Research Foundation, Inc. | Bacterial plasmin receptors as fibrinolytic agents |
| EP0672123A1 (fr) * | 1992-01-08 | 1995-09-20 | The Rockefeller University | Proteine de surface multifonctionnelle de streptococci |
| IL107458A0 (en) * | 1992-11-02 | 1994-02-27 | Gen Hospital Corp | Conjugate vaccine against group b streptococcus |
| SI0656014T1 (en) * | 1993-03-19 | 2003-12-31 | Gunnar Lindahl | Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| US6015889A (en) * | 1993-03-19 | 2000-01-18 | Gunnar Lindahl | Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| US6346392B1 (en) * | 1996-11-27 | 2002-02-12 | Smithkline Beecham Corporation | Polynucleotides encoding a novel glutamine transport ATP-binding protein |
| DE69739981D1 (de) * | 1996-10-31 | 2010-10-14 | Human Genome Sciences Inc | Streptococcus pneumoniae-Antigene und Impfstoffe |
| US7196164B2 (en) * | 1997-07-08 | 2007-03-27 | Human Genome Sciences, Inc. | Secreted protein HHTLF25 |
| US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| US7129339B1 (en) * | 1997-07-02 | 2006-10-31 | Sanofi Pasteur Limited | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| US6165763A (en) * | 1997-10-30 | 2000-12-26 | Smithkline Beecham Corporation | Ornithine carbamoyltransferase |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| WO2000037646A2 (fr) * | 1998-12-22 | 2000-06-29 | Microscience Limited | Genes, proteines, et leur utilisation |
| CA2354843A1 (fr) * | 1998-12-22 | 2000-06-29 | Microscience Limited | Proteines de surface exterieure, leurs genes, et leur utilisation |
| US6890539B2 (en) * | 1998-12-22 | 2005-05-10 | Microscience, Ltd. | Genes and proteins, and their use |
| US6605709B1 (en) * | 1999-04-09 | 2003-08-12 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics |
-
1999
- 1999-12-22 CA CA002354843A patent/CA2354843A1/fr not_active Abandoned
- 1999-12-22 KR KR1020017007910A patent/KR100818815B1/ko not_active IP Right Cessation
- 1999-12-22 DE DE69925866T patent/DE69925866T2/de not_active Expired - Fee Related
- 1999-12-22 CN CNA2005100047117A patent/CN1733800A/zh active Pending
- 1999-12-22 BR BR9916473-6A patent/BR9916473A/pt not_active Application Discontinuation
- 1999-12-22 AP AP2006003504A patent/AP2006003504A0/xx unknown
- 1999-12-22 OA OA1000162A patent/OA12425A/en unknown
- 1999-12-22 PL PL99351027A patent/PL351027A1/xx not_active IP Right Cessation
- 1999-12-22 DK DK99962421T patent/DK1140994T3/da active
- 1999-12-22 US US09/868,195 patent/US7217415B1/en not_active Expired - Fee Related
- 1999-12-22 EA EA200100701A patent/EA009885B1/ru not_active IP Right Cessation
- 1999-12-22 NZ NZ542777A patent/NZ542777A/en unknown
- 1999-12-22 EP EP99962421A patent/EP1140994B1/fr not_active Expired - Lifetime
- 1999-12-22 EP EP05009397A patent/EP1574579A3/fr not_active Withdrawn
- 1999-12-22 KR KR1020067017195A patent/KR100866170B1/ko not_active IP Right Cessation
- 1999-12-22 CN CN99814781A patent/CN1357045A/zh active Pending
- 1999-12-22 AT AT99962421T patent/ATE297995T1/de not_active IP Right Cessation
- 1999-12-22 CN CNA2008101761856A patent/CN101486756A/zh active Pending
- 1999-12-22 PT PT99962421T patent/PT1140994E/pt unknown
- 1999-12-22 WO PCT/GB1999/004376 patent/WO2000037490A2/fr not_active Application Discontinuation
- 1999-12-22 NZ NZ512296A patent/NZ512296A/en unknown
- 1999-12-22 NZ NZ525538A patent/NZ525538A/en unknown
- 1999-12-22 CZ CZ20012174A patent/CZ20012174A3/cs unknown
- 1999-12-22 ES ES99962421T patent/ES2241352T3/es not_active Expired - Lifetime
- 1999-12-22 HU HU0201022A patent/HUP0201022A3/hu unknown
- 1999-12-22 JP JP2000589559A patent/JP2002533065A/ja active Pending
- 1999-12-22 AU AU18779/00A patent/AU758722B2/en not_active Ceased
- 1999-12-22 NZ NZ552871A patent/NZ552871A/en unknown
- 1999-12-22 SI SI9930811T patent/SI1140994T1/sl unknown
-
2001
- 2001-06-21 NO NO20013101A patent/NO20013101L/no not_active Application Discontinuation
- 2001-12-20 HK HK01108929A patent/HK1039339A1/xx not_active IP Right Cessation
-
2005
- 2005-12-29 US US11/321,475 patent/US20060104990A1/en not_active Abandoned
-
2007
- 2007-01-26 KR KR1020070008368A patent/KR20070027665A/ko not_active Application Discontinuation
- 2007-08-17 US US11/892,013 patent/US20080226641A1/en not_active Abandoned
-
2008
- 2008-05-02 KR KR1020080041439A patent/KR20080052527A/ko not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69929232D1 (de) | Virusähnliche partikel zur induktion von autoantikörpern | |
| CY1105963T1 (el) | Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης | |
| PT851927E (pt) | Compostos para imunoterapia e diagnostico de tuberculose | |
| WO1996011279A3 (fr) | Reponse immunitaire amelioree par l'introduction par recombinaison du gene de la cytokine et/ou du gene de la proteine co-stimulatrice b7 dans un systeme d'expression virale | |
| CY1107950T1 (el) | Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι | |
| CY1109652T1 (el) | Lawsonia intracellularis ευρωπαϊκης προελευσεως και εμβολια, διαγνωστικοι παραγοντες και μεθοδοι χρησεως τους | |
| BR9700768A (pt) | Cepan tw928 de streptococcus equi cultura microbilóbica pura compreemdido uma bactéria vacina viva para combater infecção por streptococcus em cavalos processo par a preparação da mesma e uso da cepa tw928 de streptococcus equi | |
| ATE306938T1 (de) | Verwendung von cpg als adjuvans für hivimpstoff | |
| ATE375391T1 (de) | Chlamydia-antigene und entsprechende dna- fragmente und deren verwendungen | |
| NO20013102D0 (no) | Gener, proteiner og deres anvendelse | |
| HUP9901035A2 (hu) | Idegen DNS-t tartalmazó parapoxvírusok, előállításuk és alkalmazásuk vakcinákban | |
| DE69732029D1 (de) | Dna enthaltende impfstoffen | |
| NO20013101L (no) | Ytre overflateproteiner, deres gener og deres anvendelse | |
| CY1107560T1 (el) | Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο | |
| AR005750A1 (es) | Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion | |
| ATE454164T1 (de) | Francisella-stamm für lebenden impfstoff | |
| WO2003044047A3 (fr) | Genes de virulence, proteines, et leurs utilisations | |
| AP1679A (en) | Outer surface proteins, their genes, and their use. | |
| DE60024977D1 (de) | Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen | |
| WO2000077177A3 (fr) | Isolation d'un retrovirus humain | |
| CY1108412T1 (el) | Συνθεσεις εμβολιου που περιλαμβανουν omp85 πρωτεϊνες απο neisseria gonorrhoea και neisseria miningitidis | |
| DK1173481T3 (da) | Inaktiverede cytokiner ril immunisering | |
| WO2006098769A3 (fr) | Protection multipathogene et monopathogene contre les infections bacteriennes et virales associees a la guerre bacteriologiques, aux maladies cardiaques, et aux cancers | |
| WO2000018430A3 (fr) | Vaccins a virus actif destines a la protection de primates contre des infections et maladies dues au vih-1 | |
| WO2000029433A3 (fr) | Produit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |